GLP-1 receptor agonists like Ozempic and Wegovy have a lot of scientific data to support their use—and they can help people ...

Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...

The world's biggest food company is targeting Ozempic users with small, protein-packed meals for under $5.

An experimental weight-loss pill helped people drop 13% of their body weight in a three-month period. The results from early ...

A recent study suggests that people taking the GLP-1 liraglutide experienced more bone loss than people who exercised during ...

The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed ...

Terns Pharmaceuticals’ decision to drop its liver disease ambitions may yet pay off, after the biotech posted phase 1 data ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

GLP-1 weight loss medications like Ozempic and Wegovy have become blockbuster drugs, but the need for weekly injections has limited their use. This may soon change, as several oral versions are ...

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in ...

Phase I data for TERN-601 suggests Terns’ oral GLP-1 candidate for obesity could be a contender in the market next to big ...

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis.